| Literature DB >> 31963301 |
Fei-Xuan Wang1, Hong-Yan Li2, Yun-Qian Li2, Ling-Dong Kong3.
Abstract
The toxic reactive aldehyde 4-hydroxynonenal (4-HNE) belongs to the advanced lipid peroxidation end products. Accumulation of 4-HNE and formation of 4-HNE adducts induced by redox imbalance participate in several cytotoxic processes, which contribute to the pathogenesis and progression of oxidative stress-related human disorders. Medicinal plants and bioactive natural compounds are suggested to be attractive sources of potential agents to mitigate oxidative stress, but little is known about the therapeutic potentials especially on combating 4-HNE-induced deleterious effects. Of note, some investigations clarify the attenuation of medicinal plants and bioactive compounds on 4-HNE-induced disturbances, but strong evidence is needed that these plants and compounds serve as potent agents in the prevention and treatment of disorders driven by 4-HNE. Therefore, this review highlights the pharmacological basis of these medicinal plants and bioactive compounds to combat 4-HNE-induced deleterious effects in oxidative stress-related disorders, such as neurotoxicity and neurological disorder, eye damage, cardiovascular injury, liver injury, and energy metabolism disorder. In addition, this review briefly discusses with special attention to the strategies for developing potential therapies by future applications of these medicinal plants and bioactive compounds, which will help biological and pharmacological scientists to explore the new vistas of medicinal plants in combating 4-HNE-induced deleterious effects.Entities:
Keywords: 4-hydroxynonenal; bioactive compounds; biological activity; deleterious effects; herbs; medicinal plants
Mesh:
Substances:
Year: 2020 PMID: 31963301 PMCID: PMC7022924 DOI: 10.3390/biom10010146
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Medicinal plants and bioactive compounds in the attenuation of 4-HNE-induced deleterious effects.
| Medicinal Plants and Bioactive Compounds | Action/Mechanism | 4-HNE-Induced Model | References |
|---|---|---|---|
| Neuroprotection | |||
| Polyphenol extract | Inhibition of cleavage of PARP, reduction of ROS, protection against apoptosis | PC12 cells with apoptosis | [ |
| Quercetin | Cytoprotective effects | PC12 cell death | [ |
| Luteolin | Attenuation of cell death, caspase-3 and PARP-1 activation, mitigation of LC3 conversion and ROS production, activation of Nrf2 signaling | PC12 cells with cell viability | [ |
| Piceatannol | Cytoprotective effect, restoration of PARP cleavage and Bcl-2 expression, down-regulation of p-JNK | PC12 cell death and nuclear condensation | [ |
| Citri reticulatae viride pericarpium | Anti-inflammation | PC12 cells with inflammatory injury | [ |
| Cocoa procyanidin fraction | Attenuation of nuclear condensation, apoptotic cell death and ROS accumulation, blockade of MKK4 activity | PC12 cell death and nuclear condensation | [ |
| Trans-resveratrol | Countering the cytotoxic response, attenuation of apoptotic neurodegeneration | PC12 cells with cytotoxicity | [ |
| Sulforaphane | Increase of mitochondrial respiration | Young adult male CF-1 mice | [ |
| Kaempferol | Suppression of apoptosis and p-JNK, inhibition of NOX activation | PC12 cells with apoptosis | [ |
| Prevention of eye damage | |||
| Berberine | Restoration of autophagy, inhibition of diabetic retinopathy | Confluent human retinal Müller cells with cell death | [ |
| Cyanidin-3-glucoside | Reduction of apoptosis ratio, inflammation and angiogenesis | ARPE-19 cells | [ |
| Cyanidin-3-glucoside | Inhibition of NLRP3 inflammasome activation | ARPE-19 cells with inflammation | [ |
| Quercetin | Anti-inflammation, improvement of cell membrane integrity and mitochondrial function, decrease of IL-6, IL-8 and MCP-1 production, regulation of MAPK pathway | ARPE-19 cells with cytotoxicity | [ |
| Protection of cardiovascular injury | |||
| Oil of | Prevention of cell death, mitochondrial membrane potential loss and ROS generation | Primary cultures of neonatal rat cardiomyocytes with cell death | [ |
| Ethanolic and methanolic extracts of olive leaf | Inhibition of apoptosis, ROS production, viability impairment, mitochondrial dysfunction and pro-apoptotic activation, reduction of phosphorylation of stress-activated transcription factors | Rat cardiomyocytes with cell death | [ |
| Oleuropein | Prevention of carbonyl stress and toxicity, regulation of cellular redox status | Rat cardiomyocytes | [ |
| Reduction of ox-LDL, attenuation of MMP-1 production, inhibition of the tyrosine-phosphorylated form of platelet-derived growth factor receptor beta activation | Human coronary smooth muscle cells with injury | [ | |
| Protection against toxicity | Normal (Apc +/+) and preneoplastic (Apc min/+) immortalized epithelial colon cells with toxicity | [ | |
| Protection against liver injury | |||
| Fine root extract of ginseng with ginsenosides profiles | Inhibitory capacity against DNA damage | HepG2 cells | [ |
| Tanshinone II-A | Alleviation of hepatocyte damage | NCTC 1469 cells with damage | [ |
| 7- Hydroxycoumain | Hepatoprotection via AKR7A2 induction | HepG2 cells with cytotoxicity | [ |
| Improvement of energy metabolism disorder | |||
| Carnosic acid | Reduction of free fatty acid release, activation of pTyr632 IRS-1 and p-Akt, pSer307IRS-1, suppression of the PKA/HSL pathway activation, decrease of p-AMPK and acetyl-CoA carboxylase, alleviation of insulin resistance | 3T3-L1 adipocytes with insulin signaling impairment | [ |
| Carnosic acid | Attenuation of free fatty acid release, up-regulation of GST, reduction of 4-HNE-conjugated proteins attenuation of the lipolytic response | Human subcutaneous adipocytes with lipolysis | [ |
| 4-Hydroxytyrosol | Protection of red blood cells with oxidative damage | Hyperlipemic patients | [ |
| Repair of other disorders | |||
|
| Antioxidant capacity for the reduction of ROS | HeLa, HMEC, HaCat, and HOS cells with over-production of ROS and -HNE-protein adducts | [ |
| Capsaicin | Inhibition of oxidative stress and cell apoptosis | Human melanocytes with oxidative stress and apoptosis | [ |